---
figid: PMC6478395__nihms-755940-f0003
figtitle: BRAF mutations on tumor cell survival and the tumor microenvironment
organisms:
- NA
organisms_ner:
- Drosophila melanogaster
- Homo sapiens
pmcid: PMC6478395
filename: nihms-755940-f0003.jpg
figlink: /pmc/articles/PMC6478395/figure/F3/
number: F3
caption: Oncogenic mutations in the BRAF gene lead to constitutive signaling down
  the MAPK pathway leading to multiple deleterious effects, including tumor cell proliferation,
  angiogenesis, invasion and metastasis, and resistance to apoptosis. Importantly,
  this can also lead to immune evasion, and immunogenicity may be increased through
  treatment with BRAF inhibitors.
papertitle: Targeted Therapies Combined with Immune Checkpoint Therapy.
reftext: Peter A. Prieto, et al. Cancer J. 2016 Mar-Apr;22(2):138-146.
year: '2016'
doi: .na.character
journal_title: .na.character
journal_nlm_ta: .na.character
publisher_name: .na.character
keywords: .na.character
automl_pathway: 0.8883984
figid_alias: PMC6478395__F3
figtype: Figure
redirect_from: /figures/PMC6478395__F3
ndex: 04d64959-de9f-11ea-99da-0ac135e8bacf
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC6478395__nihms-755940-f0003.html
  '@type': Dataset
  description: Oncogenic mutations in the BRAF gene lead to constitutive signaling
    down the MAPK pathway leading to multiple deleterious effects, including tumor
    cell proliferation, angiogenesis, invasion and metastasis, and resistance to apoptosis.
    Importantly, this can also lead to immune evasion, and immunogenicity may be increased
    through treatment with BRAF inhibitors.
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - blo
  - man
  - alpha-Man-IIa
  - Pi3K21B
  - Pi3K59F
  - Pi3K68D
  - Pi3K92E
  - Dsor1
  - Mtk
  - Akt
  - Mtor
  - Tor
  - tor
  - Egfr
  - Erk7
  - rl
  - Pten
  - KIT
  - NRAS
  - RAF1
  - PIK3CA
  - PIK3CB
  - PIK3CD
  - PIK3CG
  - PIK3R3
  - PIK3R4
  - PIK3R5
  - PIK3R6
  - PIK3R1
  - PIK3R2
  - BRAF
  - MAP2K7
  - MAP2K1
  - MAP2K2
  - AKT1
  - AKT2
  - AKT3
  - MTOR
  - RORC
  - EPHB2
  - MAPK1
  - MAPK3
  - PTEN
  - Cancer
  - Lung cancer
---
